Latest Advances

  • Journal: Journal of medical case reports
  • Published —
Ganglionar tuberculosis infection evolving to hemophagocytic lymphohistiocytosis after anti-programmed cell death 1 treatment for high-risk melanoma: a case report.
  • Journal: European review for medical and pharmacological sciences
  • Published —
Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond.
  • Journal: European review for medical and pharmacological sciences
  • Published —
Implication of wide surgical excision in minimizing positive margins and consequential secondary excision - a retrospective comparative study involving 106 basal cell carcinoma cases.
  • Journal: Frontiers in immunology
  • Published —
Pembrolizumab-Induced Thyroiditis Shows PD-L1Expressing Histiocytes and Infiltrating T Cells in Thyroid Tissue - A Case Report.
  • Condition: Parasitic Infections and Cancer
  • Journal: The Korean journal of parasitology
  • Treatment Used: Albendazole and Mebendazole
  • Number of Patients: 0
  • Published —
This article discusses the use of albendazole and mebendazole in the treatment of parasitic infection and cancer.
  • Condition: Metastatic Melanoma
  • Journal: Cells
  • Treatment Used: Chimeric Antigen Receptor (CAR) T Cell Therapy
  • Number of Patients: 0
  • Published —
This article discusses the use of chimeric antigen receptor (CAR) T cell therapy in the treatment of patients with metastatic melanoma.
  • Journal: Cells
  • Published —
Emerging Role and Clinicopathological Significance of AEG-1 in Different Cancer Types: A Concise Review.
  • Condition: Oropharyngeal Non-squamous Cell Carcinoma
  • Journal: In vivo (Athens, Greece)
  • Treatment Used: Carbon-Ion Radiotherapy
  • Number of Patients: 33
  • Published —
The aim of this study was to evaluate treatment outcomes of carbon-ion radiotherapy for oropharyngeal non-squamous cell carcinoma.
  • Journal: Drug design, development and therapy
  • Published —
Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights.
  • Condition: Solid Tumors
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Pembrolizumab
  • Number of Patients: 122
  • Published —
This study examined the pharmacokinetics of pembrolizumab in the treatment of patients with solid tumors.
  • Journal: The Lancet. Oncology
  • Published —
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.
  • Condition: Melanoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Adjuvant Ipilimumab
  • Number of Patients: 1673
  • Published —
This study evaluated immune-related adverse events (irAEs) occurring from adjuvant ipilimumab in the treatment of patients with melanoma.
Showing 1-12 of 608